A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol

BACKGROUND: The U.S. Food and Drug Administration can set standards for cigarettes that could include reducing their nicotine content. Such a standard should improve public health without causing unintended serious consequences for sub-populations. This study evaluates the effect of progressive nico...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Public Health
Main Authors: Allen, Sophia I., Foulds, Jonathan, Pachas, Gladys N., Veldheer, Susan, Cather, Corinne, Azzouz, Nour, Hrabovsky, Shari, Hameed, Ahmad, Yingst, Jessica, Hammett, Erin, Modesto, Jennifer, Krebs, Nicolle M., Zhu, Junjia, Liao, Jason, Muscat, Joshua E., Richie, John, Evins, A. Eden
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2017
Assuntos:
Study Protocol
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5248523/
https://ncbi.nlm.nih.gov/pubmed/28103841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12889-016-3946-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares